Biotech Startup Ginkgo Bioworks Raises $350M Series E

Boston-based synthetic biology company Ginkgo Bioworks has raised $350 million in Series E funding. The round was led by funds managed by Baillie Gifford with participation from existing investors. Ginkgo uses automation and machine learning to engineer custom microbes for customers across multiple industries. The company plans to expand its organism engineering platform and foundry capacity.